Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona. About 40 specialist scientists will work there.
Speciality chemicals manufacturer Solenis has agreed to buy cleaning, infection prevention and hygiene giant Diversey. The $4.6 billion all-cash deal should be completed in 2H, subject to approval by Diversey shareholders, and will remove Diversey from public ownership.
An EU-wide project by ECHA’s Enforcement Forum carried out in 2021 has found that most users of substances of commonly controlled very high concern (SVHCs), mainly SMEs, already comply with the authorisation requirement to control risks.
Bachem has signed a new framework agreement to provide large volumes of peptides to an unnamed customer following a joint development project.
Cabot has announced plans for a new technology centre in Münster, Germany, which will focus on technical collaboration with customers on its battery material product lines for electric vehicles (EVs).
Holiferm has revealed that the Mayor of Wirral, Jeff Green, opened its first commercial biosurfactant plant at Ocean Park in Wallasey, UK, on 16 February.
SK Capital subsidiary Archroma has closed the acquisition of the Singapore-based Huntsman Textile Effects business. Described as a merger of equals, this will create a company over 5,000 employees in 42 countries and 35 production sites.
Current Issue
Evonik is making a “mid-double-digit million euro investment” in a production facility for its Aeroxide bra
CDMO Flamma Group is to invest about $200 million over the next three years across its network of sites in
The UK speciality chemicals industry lost one of its leading lights on 17 December 2022, when Dr David Kars
Following a review over the past few months of its of its manufacturing capacity relative to customer needs
Most Popular
Speciality chemicals manufacturer Solenis has agreed to buy cleaning, infection prevention and hygiene giant Diversey. The $4.6 billion all-cash deal should be completed in 2H, subject to approval by Diversey shareholders, and will remove Diversey from public ownership. Both boards have backed it.
Bachem has signed a new framework agreement to provide large volumes of peptides to an unnamed customer following a joint development project. This covers “a committed volume at an equivalent value of over CHF 500 million for the five-year period of 2027-2031, with significant upside potential,” the company said.
This follows recent deals a previous large-volume contract for another unnamed customer worth CHF 175 million in 2023-4. The deal was announced in September 2022 and subsequently upgraded with a further work order for a minimum total of CHF 1 billion from 2025 to 2029.
Holiferm has revealed that the Mayor of Wirral, Jeff Green, opened its first commercial biosurfactant plant at Ocean Park in Wallasey, UK, on 16 February. Present were representatives of the global biosurfactant community, including people from Japan, Thailand, South Africa, Germany, France, Belgium and Australia.
